Bitget App
Trade smarter
Buy cryptoMarketsTradeFuturesStocksEarnInstitutionAI & More
StakeStone (STO) 24-hour amplitude at 74.9%: Large whale transfers and surging trading volume drive extreme volatility

StakeStone (STO) 24-hour amplitude at 74.9%: Large whale transfers and surging trading volume drive extreme volatility

Bitget PulseBitget Pulse2026/04/04 16:02
Show original
By:Bitget Pulse

Volatility Overview

Over the past 24 hours, STO's price hit a low of $0.11256 and a high of $0.1969, currently trading at $0.17736, with a fluctuation range of 74.9%. Trading volume surged to approximately $313 million (an increase of 16%), far exceeding its market capitalization. Net capital outflow was about $80,000 across all CEXs, but some exchanges, such as Bitget, recorded a net inflow of $630,000.

Brief Analysis of Price Fluctuation Causes

- Whale-led Transfers: On April 3, a new wallet withdrew 25.5 million STO (accounting for 11% of circulating supply) from Binance in a single transaction, directly removing exchange liquidity and driving the price sharply up from around $0.11.

- Amplified Trading Volume and Speculation: 24-hour trading volume soared to $955 million (7 times the market cap), accompanied by increased positions and $2.325 billion in liquidations ($726 million long, $1.57 billion short), intensifying volatility.

- Supply Concentration Risk: The top 10 holders control 98.9% of the supply, with three addresses holding 88%, making the token highly susceptible to whale actions.

Market Views and Outlook

The mainstream sentiment in the community is cautiously optimistic: X discussions view whale accumulation as a short-term bullish signal but warn of manipulation risks and high concentration. If STO holds the $0.18 level, predictions see further gains to $0.24–0.28; otherwise, a pullback to $0.14 is expected. Analysts highlight that selling pressure is common after large liquidations, so short-term volatility may persist.

Note: This analysis is AI-generated based on publicly available data and on-chain monitoring. For informational reference only.
0
0

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

Understand the market, then trade.
Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.
Trade now!

You may also like

U.S. non-farm payrolls surge by 165,000 in October, far exceeding expectations! Unemployment rate unexpectedly drops to 4.1%, December rate hike expectations intensify

In October, US non-farm payrolls increased by 165,000, which is 2.5 times the Wall Street median forecast of 65,000 and represents an exceptionally strong deviation of about 5 standard deviations, exceeding the upper limit of all institutional forecast ranges. The unemployment rate unexpectedly fell from 4.2% to 4.1%, while the market had expected it to remain unchanged; average hourly wages also accelerated year-on-year growth to 3.1%. Meanwhile, the previous two months' non-farm payrolls were revised upwards by a total of 84,000. Following the release of the data, the yield on 2-year US Treasury bonds rose by 7 basis points, and the pricing of the probability of a Fed rate hike in December climbed to 70%.

华尔街见闻•2026/11/06 15:01

AI Sell-off Hits Anthropic IPO, Potential Valuation Expected to Drop to $1.2–1.3 Trillion

The valuation range discussed by potential investors has been lowered from the previous high of $2 trillion to between $1.2 trillion and $1.3 trillion, and some strategists have even suggested going below $1 trillion to ensure safety. In the face of significant market volatility and financial concerns such as quarterly losses, Anthropic is facing tough decisions, including a discounted valuation, reducing the size of the offering, or postponing the listing.

华尔街见闻•2026/11/06 13:42
AI Sell-off Hits Anthropic IPO, Potential Valuation Expected to Drop to $1.2–1.3 Trillion

Moderna Q3 revenue up 29% year-on-year, far exceeding expectations, raises full-year revenue growth guidance to 15%-25% | Earnings Report Insight

Moderna's Q3 revenue increased by 29% year-on-year to $1.31 billion, with profits significantly exceeding expectations. The company raised its 2026 revenue growth guidance to 15%-25%. The ramp-up of next-generation COVID-19 and flu vaccines, along with international market expansion, has driven performance improvement. Phase III data for the personalized cancer vaccine has also shown positive progress. The company is simultaneously advancing cost reduction and pipeline R&D, with year-end cash expectations significantly raised.

华尔街见闻•2026/11/06 13:23